WO2013183748A1 - 口腔用組成物 - Google Patents
口腔用組成物 Download PDFInfo
- Publication number
- WO2013183748A1 WO2013183748A1 PCT/JP2013/065786 JP2013065786W WO2013183748A1 WO 2013183748 A1 WO2013183748 A1 WO 2013183748A1 JP 2013065786 W JP2013065786 W JP 2013065786W WO 2013183748 A1 WO2013183748 A1 WO 2013183748A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- composition
- component
- less
- oral
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 215
- 150000003839 salts Chemical class 0.000 claims abstract description 52
- 239000002253 acid Substances 0.000 claims abstract description 46
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229940005657 pyrophosphoric acid Drugs 0.000 claims abstract description 20
- 210000000214 mouth Anatomy 0.000 claims description 92
- 239000007788 liquid Substances 0.000 claims description 32
- 239000000551 dentifrice Substances 0.000 claims description 31
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 29
- 239000000194 fatty acid Substances 0.000 claims description 29
- 229930195729 fatty acid Natural products 0.000 claims description 29
- -1 alkali metal salt Chemical class 0.000 claims description 26
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 125000002252 acyl group Chemical group 0.000 claims description 11
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 10
- 150000005846 sugar alcohols Chemical class 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 9
- 239000004376 Sucralose Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 235000019408 sucralose Nutrition 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 239000002736 nonionic surfactant Substances 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 74
- 108090000623 proteins and genes Proteins 0.000 abstract description 74
- 230000000694 effects Effects 0.000 abstract description 64
- 238000004140 cleaning Methods 0.000 abstract description 42
- 238000010186 staining Methods 0.000 abstract 2
- 235000018102 proteins Nutrition 0.000 description 72
- 235000019640 taste Nutrition 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 20
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 16
- 235000019658 bitter taste Nutrition 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 14
- 239000002689 soil Substances 0.000 description 13
- 230000001629 suppression Effects 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 239000008213 purified water Substances 0.000 description 10
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 9
- 230000001680 brushing effect Effects 0.000 description 8
- 239000001506 calcium phosphate Substances 0.000 description 8
- 229960001714 calcium phosphate Drugs 0.000 description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 description 8
- 235000011010 calcium phosphates Nutrition 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 230000007505 plaque formation Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 8
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 7
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 7
- 239000011230 binding agent Substances 0.000 description 7
- 229910001424 calcium ion Inorganic materials 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 235000013922 glutamic acid Nutrition 0.000 description 7
- 239000004220 glutamic acid Substances 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 6
- MTJZWYHTZFVEGI-INIZCTEOSA-N (2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O MTJZWYHTZFVEGI-INIZCTEOSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000000594 mannitol Substances 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 235000019643 salty taste Nutrition 0.000 description 6
- 239000004386 Erythritol Substances 0.000 description 5
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 235000011180 diphosphates Nutrition 0.000 description 5
- 235000019414 erythritol Nutrition 0.000 description 5
- 229940009714 erythritol Drugs 0.000 description 5
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229940011037 anethole Drugs 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000005187 foaming Methods 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 206010013911 Dysgeusia Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000012888 bovine serum Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229940048084 pyrophosphate Drugs 0.000 description 3
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 229940048086 sodium pyrophosphate Drugs 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 3
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- VCRXMSMANOGRCM-UHFFFAOYSA-N 2-(dodecanoylamino)butanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CC(O)=O VCRXMSMANOGRCM-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000010069 protein adhesion Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 2
- 229940067741 sodium octyl sulfate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 2
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 2
- WFRKJMRGXGWHBM-UHFFFAOYSA-M sodium;octyl sulfate Chemical compound [Na+].CCCCCCCCOS([O-])(=O)=O WFRKJMRGXGWHBM-UHFFFAOYSA-M 0.000 description 2
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000090599 Plantago psyllium Species 0.000 description 1
- 235000010451 Plantago psyllium Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000011086 high cleaning Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000007517 polishing process Methods 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to an oral composition.
- Patent Document 1 discloses a dentifrice composition containing N-long chain acylglutamate as such a surfactant.
- an amino acid surfactant is used in the oral composition described in Patent Document 2. It is trying to obtain the stain formation inhibitory effect by mix
- acyl amino acid salts known as amino acid-based surfactants with little irritation to skin and mucous membranes may cause bitterness for example, Patent Document 3 discloses 0.5 mass of acyl amino acid salts.
- strengthening by using glucose fatty acid ester together with this is disclosed, maintaining favorable taste by setting it as a small quantity below%.
- Patent Document 4 discloses water-soluble polyphosphates such as alkyl sulfates and pyrophosphates.
- An oral composition containing at least 1% by weight and orthophosphate is disclosed, and it is described that such composition enhances the chemical cleaning effect against stains on tooth surfaces such as stains, plaques, tobacco spears and the like.
- Patent Document 5 discloses a toothpaste containing an anionic surfactant, a water-soluble pyrophosphate 0.3 to 1.5% by mass, and a specific hydroxypropyl cellulose in order to exert an excellent tooth dirt removing effect.
- a composition is disclosed.
- JP-A-2-256608 Japanese Patent Laid-Open No. 10-17444 Japanese Patent Laid-Open No. 3-200714 JP-A-9-12438 JP 2007-161657 A
- Various stains attached to the tooth surface including the stains, plaques, and cigarettes mentioned above, further form bacterial co-aggregation and other inorganic stain layers on the protein stain formed on the tooth surface. It becomes. Therefore, if protein stains intervening between the tooth surface and stains such as stains and plaques are effectively removed, the stains such as stains and plaques can be removed by uprooting, and the cleaning effect can be enhanced. . Furthermore, if the protein stain can be prevented from adhering to the tooth surface, the effect of suppressing plaque formation can be greatly expected.
- the details of the calculus formation process are not necessarily clarified, but calcium supplied from saliva or exudate to organic substances such as bacteria that form plaques on the tooth surface or adhesive dextran It is considered that the calcification phenomenon of plaque occurs due to the adhesion of phosphorus and crystallization. And this inorganic component is a hydroxyapatite-like calcification.
- compositions for oral cavity that allow the user to easily realize such a cleaning effect are preferred.
- increasing the resistance with respect to a cavity and providing a favorable taste is also desired by using a composition for oral cavity.
- Patent Documents 1 to 3 Even if an amino acid surfactant is used as in Patent Documents 1 to 3, the removal performance of protein stains on teeth cannot be obtained, and depending on the components used and the amount of the combination, a good taste may be brought about. It can be difficult.
- blending polyphosphates such as pyrophosphates does not provide both the effect of removing protein stains and the effect of preventing adhesion, and the blending amount thereof. There is a possibility that the feeling of teeth after washing in the oral cavity may be reduced as the amount increases, and thus the cleaning effect may not be fully realized.
- none of the above-mentioned documents has made any study on enhancing acid resistance or imparting good low-temperature stability.
- the present invention can sufficiently remove protein stains present on the tooth surface, and can effectively prevent protein stains from adhering to the tooth surface, and realizes the cleaning effect well in the oral cavity.
- the present invention relates to an oral composition that has excellent acid resistance and good low-temperature stability, and can enhance taste and feeling of use.
- the present inventors have made various studies, and while containing N-acylamino acid or a salt thereof and pyrophosphoric acid or a salt thereof in a specific amount, by making these into a specific quantitative ratio and a specific total amount, It has been found that an oral composition having an excellent acid resistance and a good low-temperature stability can be obtained while enhancing the removal effect of protein stains and the anti-adhesion effect, realizing a good cleaning effect in the oral cavity. .
- it is the composition for oral cavity of the present invention it is possible to suppress the calcium phosphate deposited in the plaque from being transferred to the hydroxyapatite crystal and further growing, so that it is more effective in inhibiting plaque formation. I found that I can expect.
- the composition for oral cavity of the present invention also has excellent acid resistance, it can effectively suppress elution of calcium ions from the tooth surface, and also has good stability in a low temperature environment. It was found that the present invention can maintain a good taste by suppressing the expression of unpleasant tastes such as bitterness and salty taste.
- the present invention includes the following components (A) and (B): (A) N-acylamino acid or salt thereof 0.005 mass% or more and 0.3 mass% or less and (B) pyrophosphoric acid or salt thereof 0.005 mass% or more and 0.5 mass% or less, ) And component (B) mass ratio ((B) / (A)) is 0.05 or more and 40 or less, and the total content of component (A) and component (B) is 0.01% by mass or more. It is related with the composition for oral cavity which is 0.6 mass% or less.
- the composition for oral cavity of the present invention has an excellent effect of removing protein stains on the tooth surface and an effect of suppressing the adhesion of protein stains on the tooth surface, and after using the oral composition, the tooth surface is smooth. You can feel that it has a smooth feel, you can fully expect the plaque formation inhibitory effect and can also improve the cleaning effectiveness, and also have excellent acid resistance and good low temperature stability, It is possible to have a good taste.
- the oral composition of the present invention contains 0.005% by mass or more and 0.3% by mass or less of N-acylamino acid or a salt thereof (A).
- A N-acylamino acid or a salt thereof
- By containing such a component (A) in a specific amount it is possible to effectively suppress adhesion while effectively removing protein stains in combination with a specific amount of pyrophosphoric acid or a salt thereof (B) described later. can do.
- the oral cavity after using the oral composition of the present invention it is possible to feel when the tooth surface is in a smooth state without dirt, enhancing the feel of slippery without squeezing, so-called The cleaning effectiveness can be sufficiently enhanced.
- the slippery touch without the squeezing feeling refers to a smooth feel of the tooth surface that allows the tongue to slide with almost no friction when the tooth surface is touched with the tongue.
- the acyl group of N-acylamino acid is from the viewpoint of combining excellent protein soil removal effect and adhesion suppression effect, from the viewpoint of providing good cleaning effectiveness, and from the viewpoint of providing excellent acid resistance and good low-temperature stability.
- the acyl group is preferably an acyl group having 10 to 20 carbon atoms, more preferably an acyl group having 10 to 18 carbon atoms, and further preferably an acyl group having 12 to 18 carbon atoms. Is still more preferred.
- the acyl group is preferably one or more selected from capriloyl group, lauroyl group, myristoyl group, palmitoyl group, stearoyl group and cocoyl group from the viewpoint of bubbling of the oral composition and ease of handling, and lauroyl.
- One or more selected from a group, a myristoyl group and a cocoyl group are more preferable, and one or more selected from a lauroyl group and a myristoyl group are more preferable.
- the amino acid part of the N-acylamino acid is preferably one or more selected from glutamic acid, aspartic acid, glycine, alanine, threonine, methylalanine, sarcosine, lysine and arginine.
- the amino acid part of the N-acylamino acid is acidic from the viewpoint of improving the effect of removing protein stains and preventing the adhesion of stains in combination with component (B), and providing excellent acid resistance and good low-temperature stability. It is preferably an amino acid, more preferably one or two selected from glutamic acid and aspartic acid, and even more preferably glutamic acid. Further, these amino acid moieties may be any of D-form, L-form, or a mixture of D-form and L-form, and is preferably L-form.
- N-acylamino acid or a salt thereof includes N-lauroyl glutamic acid, N from the viewpoint of improving the effect of removing protein stains and suppressing adhesion, and providing excellent acid resistance and good low-temperature stability.
- N-lauroyl glutamic acid from the viewpoint of improving the effect of removing protein stains and suppressing adhesion, and providing excellent acid resistance and good low-temperature stability.
- one or more selected from myristoyl glutamic acid, N-cocoyl glutamic acid, N-lauroyl aspartic acid and salts thereof selected from N-lauroyl glutamic acid, N-myristoyl glutamic acid, N-cocoyl glutamic acid and salts thereof More preferably, one or more selected from N-lauroyl glutamic acid, N-myristoyl glutamic acid and salts thereof are more preferable.
- salts of N-acyl amino acid salts include alkali metal salts such as sodium and potassium; alkaline earth metal salts such as calcium and magnesium; other inorganic salts such as aluminum and zinc; ammonium salts; monoethanolamine, diethanolamine, tri Organic amine salts such as ethanolamine; basic amino acid salts such as arginine, lysine, histidine, ornithine and the like. These may be used alone or in combination of two or more.
- an alkali metal salt is preferable and a sodium salt is more preferable from the viewpoint of flavor and availability.
- the composition for oral cavity of the present invention is 0.005% by mass or more, preferably 0.007% by mass. It is above, More preferably, it is 0.01 mass% or more.
- the content of N-acylamino acid or a salt thereof (A) improves the effect of removing protein stains and suppresses adhesion due to the combined use with component (B) described below, and suppresses bitterness and gummy taste, resulting in an effective cleaning effect.
- the composition for oral cavity of the present invention is 0.3% by mass or less, preferably 0.2% by mass or less, more preferably 0.1% by mass or less.
- the content of N-acylamino acid or a salt thereof (A) is 0.005 to 0.3% by mass in the oral composition of the present invention, preferably 0.007 to 0.2% by mass. %, More preferably 0.01 to 0.1% by mass.
- the oral composition of the present invention contains 0.005 mass% or more and 0.5 mass% or less of pyrophosphoric acid or a salt thereof (B).
- a component (B) in a specific amount, combined with the component (A), the effect of removing protein stains and the effect of suppressing adhesion are dramatically enhanced while the composition is used in the oral cavity.
- the cleaning effect can be sufficiently enhanced, and in addition, excellent acid resistance and good low-temperature stability can be provided.
- the salt of pyrophosphate is preferably a sodium salt or a potassium salt from the viewpoint of solubility in water.
- These pyrophosphoric acids or salts (B) thereof may be used alone or in combination of two or more. Also good.
- a sodium pyrophosphate is preferable from a viewpoint of the removal effect of protein stain
- the content of pyrophosphoric acid or a salt thereof (B) is synergistically enhanced with the above component (A) to remove protein stains and to prevent adhesion, has a cleaning effect, and has excellent acid resistance and good
- the composition for oral cavity of the present invention is 0.005% by mass or more, preferably 0.007% by mass or more, more preferably 0.01% by mass or more. is there.
- content of pyrophosphoric acid or its salt (B) suppresses a feeling of squeaking, suppresses the fall of a cleaning effective feeling, and prevents that a flavor is impaired.
- the content of pyrophosphoric acid or a salt thereof (B) is 0.005 to 0.5% by mass, preferably 0.007 to 0.5% by mass in the oral composition of the present invention. More preferably, the content is 0.01 to 0.5% by mass, still more preferably 0.01 to 0.4% by mass, and still more preferably 0.01 to 0.15% by mass.
- the total content of the N-acylamino acid or its salt (A) and the content of pyrophosphoric acid or its salt (B) is good while synergistically enhancing the protein soil removal effect and the adhesion inhibiting effect.
- the content is 0.01% by mass or more, and preferably 0.02% by mass or more.
- the sum total of content of a component (A) and a component (B) is 0.6 mass from a viewpoint of improving the removal effect and adhesion suppression effect of the protein stain
- the total content of the component (A) and the component (B) is 0.01 to 0.6% by mass, preferably 0.01 to 0.45% by mass, more preferably 0.00. It is 02 to 0.45% by mass, more preferably 0.02 to 0.3% by mass, and still more preferably 0.02 to 0.2% by mass.
- the mass ratio ((B) / (A)) of the N-acylamino acid or its salt (A) to pyrophosphoric acid or its salt (B) maintains the good flavor and removes and removes protein stains. From the viewpoint of synergistically increasing the suppression effect, from the viewpoint of providing a cleaning effect, and from the viewpoint of providing excellent acid resistance and good low-temperature stability, it is 0.05 or more, preferably 0.1 or more, 40 or less, preferably 15 or less, more preferably 12 or less.
- the mass ratio ((B) / (A)) is 0.05 to 40, preferably 0.1 to 40, more preferably 0.1 to 15, and more preferably 0.00. 1-12.
- the composition for oral cavity of the present invention has a viewpoint of securing a good feeling of use while suppressing the foaming from being lowered by the component (A), a viewpoint of coexistence of the effect of suppressing the adhesion of protein dirt and the effect of removing the protein dirt, Moreover, when the composition for oral cavity of this invention is a dentifrice composition so that it may mention later, it is preferable to contain alkyl sulfate (C) 0.5 mass% or more and 2 mass% or less further.
- examples of the alkyl sulfate include one or more selected from sodium lauryl sulfate, sodium myristyl sulfate, sodium palmityl sulfate, sodium stearyl sulfate, sodium octyl sulfate, and sodium capryl sulfate.
- alkyl sulfate (C) sodium lauryl sulfate is preferable from the viewpoint of obtaining the protein soil removal effect while ensuring the protein soil adhesion inhibitory effect.
- the content of the alkyl sulfate (C) is preferably 0.5% by mass in the oral composition of the present invention, from the viewpoint of ensuring good foaming, the effect of suppressing the adhesion of protein stains, and good usability. More preferably, it is 0.8% by mass or more, more preferably 1% by mass or more, preferably 2% by mass or less, more preferably 1.7% by mass or less, Preferably it is 1.5 mass% or less.
- the content of the alkyl sulfate (C) is preferably 0.5 to 2% by mass, more preferably 0.8 to 1.7% by mass in the oral composition of the present invention. More preferably, it is 1 to 1.5% by mass.
- the mass ratio ((C) / (A)) of the N-acylamino acid or its salt (A) to the alkyl sulfate (C) sufficiently exhibits the effect of suppressing the adhesion of protein stains while maintaining good foaming. From the viewpoint of making it, it is preferably 5 or more, more preferably 10 or more, preferably 200 or less, more preferably 150 or less.
- the mass ratio ((C) / (A)) is preferably 5 to 200, more preferably 10 to 150.
- composition for oral cavity of the present invention further improves the refreshing effect and increases the cleaning effect, and improves the bitterness specific to the component (A), and further improves the taste, etc., at 20 ° C. with respect to 100 g of the aqueous solution. It is preferable to contain 5 to 40 g of dissolved sugar alcohol (D).
- the said aqueous solution means the aqueous solution which melt
- sugar alcohol (D) examples include erythritol, mannitol, ⁇ -D-glucopyranosyl-1,6-sorbitol, ⁇ -D-glucopyranosyl-1,6-mannitol, from the viewpoint of a refreshing feeling in the oral cavity and a good flavor.
- One or more selected from reduced palatinose which is a mixture of ⁇ -D-glucopyranosyl-1,6-sorbitol and ⁇ -D-glucopyranosyl-1,6-mannitol, is preferable, and from the viewpoint of moderate solubility and taste Erythritol and reduced palatinose are more preferable, and erythritol is preferable from the viewpoint of a good refreshing feeling.
- the content of the component (D) is preferably 20% by mass or more, more preferably 25 in the composition for oral cavity of the present invention from the viewpoint of obtaining a refreshing refreshing effect and maintaining a good taste. It is at least mass%, more preferably at least 30 mass%, preferably at most 60 mass%, more preferably at most 55 mass%, still more preferably at most 50 mass%.
- the content of component (D) is preferably 20 to 60% by mass, more preferably 25 to 55% by mass, and further preferably 30 to 50% by mass in the oral composition of the present invention. It is.
- the composition for oral cavity of the present invention preferably further contains other sugar alcohol that dissolves more than 40 g with respect to 100 g of the aqueous solution at 20 ° C., in addition to the component (D), from the viewpoint of taste and usability.
- other sugar alcohols those selected from sorbitol and xylitol are preferable, and sorbitol that also functions as a wetting agent is preferable.
- the content of the sugar alcohol other than the component (D) is preferably 10% by mass or more, more preferably 15% by mass or more, and more preferably 30% by mass or less in the composition for oral cavity of the present invention from the viewpoint of usability. Is preferred.
- the oral composition of the present invention is a liquid oral composition
- the content of the sugar alcohol other than the component (D) depends on the taste and feeling of use, and is deposited on the mouth of the container.
- the composition for oral cavity of the present invention is preferably 10% by mass or less, more preferably 8% by mass or less, preferably 1% by mass or more, and preferably 2% by mass or more. More preferably.
- the form of the composition for oral cavity of the present invention is not particularly limited as long as it can be applied to the mouth, and is a dentifrice composition such as a toothpaste or a powder dentifrice, or a liquid oral cavity such as a mouthwash or a liquid dentifrice. It can be used as a composition.
- a dentifrice composition such as a toothpaste or a powder dentifrice
- a liquid oral cavity such as a mouthwash or a liquid dentifrice.
- a liquid oral composition selected from a mouthwash and a liquid dentifrice is preferable, and physical cleaning with a toothbrush is preferable. Toothpastes are preferred from the viewpoint of enhancing the effect of removing protein stains and the effect of adhesion by the combined use.
- the oral composition of the present invention contains water in addition to the above components. Thereby, component (A) and component (B) can be favorably diffused in the oral cavity while being dissolved or dispersed, and the protein soil removal effect and adhesion suppression effect can be effectively exhibited.
- the content of such water is preferably 10% by mass or more, more preferably 12% by mass in 100% by mass of the dentifrice composition of the present invention. % Or more, preferably 60% by mass or less, more preferably 50% by mass or less.
- the water content is preferably 10 to 60% by mass, more preferably 12 to 100% by mass in 100% by mass of the dentifrice composition of the present invention. 50% by mass.
- the content of such water is preferably 50% by mass or more in 100% by mass of the liquid oral composition of the present invention. Preferably it is 70 mass% or more, More preferably, it is 80 mass% or more.
- the content of water in 100% by mass of the liquid oral composition of the present invention is the balance of the other components, preferably 99.99% by mass or less, more preferably 99.98% by mass or less, More preferably, it is less than 99.98 mass%.
- the oral composition of the present invention is a liquid oral composition and further contains a nonionic surfactant (F)
- the content of such water is in 100% by mass of the liquid oral composition of the present invention.
- the oral composition of the present invention is a liquid oral composition
- the water content is preferably 50 to 99.99% by mass in 100% by mass of the liquid oral composition of the present invention. More preferably, it is 70 to 99.98% by mass, still more preferably 80 to 90% by mass, still more preferably 86 to 95% by mass, and further preferably 86 to 92% by mass.
- the oral composition of the present invention is a dentifrice composition
- its water content can be calculated from the blended moisture content and the moisture content in the blended component, but is measured, for example, with a Karl Fischer moisture meter. be able to.
- a Karl Fischer moisture meter for example, a trace moisture measuring device (Hiranuma Sangyo Co., Ltd.) can be used. In this apparatus, 5 g of the dentifrice composition can be taken and suspended in 25 g of anhydrous methanol, and 0.02 g of this suspension can be collected to measure the amount of water.
- the oral composition of the present invention is a dentifrice composition
- a binder (E) sodium alginate, sodium carboxymethyl cellulose, carrageenan, xanthan gum, sodium polyacrylate, hydroxyethyl cellulose, hydroxypropyl cellulose, pectin, tragacanth gum, gum arabic, guar gum, caraya gum, locust bean gum, gellan gum, tamarind
- the binder (E) is preferably one or more selected from sodium carboxymethylcellulose, carrageenan, and xanthan gum having a degree of etherification of 0.7 to 2.0, and more preferably two or more.
- the content of the binder (E) is preferably 0.3% by mass or more, more preferably 0.4% by mass or more, and preferably 2% by mass or less in the oral composition of the present invention. More preferably, it is 1.5 mass% or less. In addition, the content of the binder (E) is preferably 0.3 to 2% by mass, more preferably 0.4 to 1.5% by mass in the oral composition of the present invention.
- the oil absorption amount measured by a method according to JIS K5101-13-1 is 200 to 400 mL together with the binder (E). / 100 g) is preferably contained in an amount of 1% by mass to 12% by mass.
- an abrasive can be further contained within a range that does not impair the effects of the present invention.
- the abrasive include calcium phosphate, calcium hydrogen phosphate, calcium carbonate, aluminum hydroxide, aluminum silicate, zirconium silicate, abrasive silica (oil absorption measured by a method according to JIS K5101-13-3 is 50 ⁇ 150 mL / 100 g).
- RDA value Radioactive Dentine Abrasion values, a value measured by ISO 11609 abrasiveness test method Appendix A
- the composition for oral cavity of the present invention brings about excellent cleaning effectiveness in addition to the high protein soil removal effect and adhesion suppression effect, and therefore can exhibit excellent effects even if the content of the abrasive is reduced. it can.
- the content of the abrasive is preferably 1% by mass or more, preferably 20% by mass or less, and more preferably 10% by mass or less in the composition for oral cavity of the present invention.
- the oral composition of the present invention preferably further contains a nonionic surfactant (F).
- a nonionic surfactant F
- the acid resistance can be enhanced to effectively suppress the elution of calcium ions from the tooth surface, and good low temperature stability can be imparted. Moreover, it can also suppress effectively that the calcium-phosphate component precipitated in the plaque adheres to hydroxyapatite.
- the component (F) include polyglycerin fatty acid ester, sucrose fatty acid ester, and polyoxyethylene hydrogenated castor oil having an average added mole number of less than 60, preferably an average added mole number of 40 or less. These may be used individually by 1 type and may be used in combination of 2 types. Among these, from the viewpoint of effectively enhancing acid resistance, suppressing adhesion of calcium phosphate, and effectively imparting low-temperature stability, one or more selected from polyglycerin fatty acid ester and sucrose fatty acid ester are preferable.
- the component (F) polyglycerol fatty acid ester is preferably derived from a fatty acid having 12 to 20 carbon atoms, more preferably derived from a fatty acid having 12 to 18 carbon atoms.
- the polyglycerin fatty acid ester of component (F) is preferably one having an average degree of condensation of glycerin of 2 to 20, and more preferably one having an average degree of condensation of glycerin of 5 to 12.
- the content of the component (F) is preferably 0.01% by mass or more in the oral composition of the present invention from the viewpoint of enhancing acid resistance, suppressing adhesion of calcium phosphate, and imparting low temperature stability. More preferably, it is 0.05 mass% or more, More preferably, it is 0.1 mass% or more, More preferably, it is 0.15 mass% or more.
- the content of the component (F) is preferably 2% by mass or less, more preferably 1% by mass or less, and still more preferably 0 in the composition for oral cavity of the present invention from the viewpoint of taste and feeling of use. 0.8 mass% or less.
- the content of the component (F) is preferably 0.01 to 2% by mass, more preferably 0.05 to 1% by mass, and still more preferably 0% in the oral composition of the present invention. 0.1 to 0.8% by mass, and more preferably 0.15 to 0.8% by mass.
- the composition for oral cavity of the present invention further improves the strong bitter taste and the bitter taste caused by the coexistence of components (A) to (C), in addition to the bitter taste specific to component (A) and the salty taste specific to component (B). Therefore, it is preferable to contain sucralose (G).
- the content of the component (G) is preferably 0.001% by mass or more, more preferably 0.005% by mass or more, and further preferably 0.008% by mass in the composition for oral cavity of the present invention. % Or more.
- the content of sucralose (G) is preferably 0.1% by mass or less in the oral composition of the present invention, more preferably from the viewpoint of preventing a decrease in the refreshing feeling of the oral composition.
- Sucralose also known as 4,1 ', 6'-trichlorogalactosucrose, has a structure in which three of sucrose's hydroxyl groups are selectively substituted with chlorine atoms. Saneihara FFI Co., Ltd. Sucralose marketed by the company can be obtained.
- the mass ratio ((A) + (B)) / (G) of the N-acylamino acid or its salt (A) and pyrophosphoric acid or its salt (B) to sucralose (G) is excellent in cleaning performance. From the viewpoint of further ensuring compatibility with the realization of a good taste, it is preferably 0.5 or more, more preferably 1 or more, and even more preferably 1.5 or more.
- the mass ratio ((A) + (B)) / (G) is preferably 30 or less, and more preferably 25 or less, from the viewpoint of further ensuring compatibility between cleaning effectiveness and achieving a good taste. More preferably, it is 12 or less.
- the mass ratio ((A) + (B)) / (G) is preferably 0.5 to 30, more preferably 1 to 25, and further preferably 1.5 to 12.
- the oral composition of the present invention preferably contains a fragrance composition from the viewpoint of improving the taste together with the component (G).
- perfume compositions include sesquiterpene hydrocarbons such as pinene, myrcene, limonene, tarpinene and cymene; sesquiterpene aldehydes such as citral, citronellal and perilaldehyde; citrus oils such as orange, lemon and lime oil; A perfume composition containing an aromatic alcohol such as thymol and eugenol; and a natural essential oil such as bergamot. These may be used alone or in combination of two or more.
- a fragrance composition containing a fragrance selected from anethole, thymol, and eugenol is preferred, and a fragrance composition containing at least anethole is more preferred.
- Anethole is preferably contained in the fragrance composition in an amount of 0.3% by mass to 20% by mass.
- the composition for oral cavity of the present invention further includes a fluoride ion supply compound such as tin fluoride, sodium fluoride and ammonium fluoride, and a fluoride such as sodium monofluorophosphate as long as the effects of the present invention are not impaired.
- a fluoride ion supply compound such as tin fluoride, sodium fluoride and ammonium fluoride
- a fluoride such as sodium monofluorophosphate as long as the effects of the present invention are not impaired.
- This invention discloses the following oral compositions further regarding the embodiment mentioned above.
- the composition for oral cavity which is 0.6 mass% or less.
- the mass ratio ((B) / (A)) of the component (A) to the component (B) is 0.05 or more, preferably 0.1 or more, and 40 or less, preferably The composition for oral cavity according to the above [1], which is 15 or less, more preferably 12 or less.
- the total content of the component (A) and the component (B) is 0.01% by mass or more, preferably 0.02% by mass or more, and 0.6% by mass or less, The composition for oral cavity according to the above [1] or [2], which is preferably 0.45% by mass or less, more preferably 0.3% by mass or less.
- component (A) is 0.005% by mass or more, preferably 0.007% by mass or more, more preferably 0.01% by mass or more, and 0.3% by mass.
- Component (A) preferably has an acyl group having 6 to 22 carbon atoms, more preferably an acyl group having 10 to 20 carbon atoms, and still more preferably an acyl group having 10 to 18 carbon atoms.
- Component (A) is preferably one or more selected from N-lauroyl glutamic acid, N-myristoyl glutamic acid, N-cocoyl glutamic acid, N-lauroyl aspartic acid and salts thereof, more preferably One or more selected from N-lauroyl glutamic acid, N-myristoyl glutamic acid, N-cocoyl glutamic acid and salts thereof, more preferably 1 selected from N-lauroyl glutamic acid, N-myristoyl glutamic acid and salts thereof.
- the content of component (B) is 0.005% by mass or more, preferably 0.007% by mass or more, more preferably 0.01% by mass or more, and 0.5% by mass.
- composition for oral cavity according to any one of the above [1] to [9], further comprising an alkyl sulfate (C).
- Component (C) is preferably one or more selected from sodium lauryl sulfate, sodium myristyl sulfate, sodium palmityl sulfate, sodium stearyl sulfate, sodium octyl sulfate and sodium capryl sulfate, more preferably lauryl.
- the composition for oral cavity according to the above [10] which is sodium sulfate.
- the content of the component (C) is preferably 0.5% by mass or more, more preferably 0.8% by mass or more, further preferably 1% by mass or more, preferably 2% by mass.
- the mass ratio ((C) / (A)) of the component (A) to the component (C) is preferably 5 or more, more preferably 10 or more, preferably 200 or less, more
- composition for oral cavity according to any one of the above [1] to [13], further comprising a sugar alcohol (D) that dissolves 5 to 40 g with respect to 100 g of an aqueous solution at 20 ° C.
- Component (D) is preferably erythritol, mannitol, ⁇ -D-glucopyranosyl-1,6-sorbitol, ⁇ -D-glucopyranosyl-1,6-mannitol, ⁇ -D-glucopyranosyl-1,6-sorbitol
- the oral composition of [14] above which is one or more selected from reduced palatinose, which is a mixture of ⁇ -D-glucopyranosyl-1,6-mannitol, more preferably erythritol.
- the content of component (D) is preferably 20% by mass or more, more preferably 25% by mass or more, still more preferably 30% by mass or more, and preferably 60% by mass or less. More preferably, it is 55 mass% or less, More preferably, it is 50 mass% or less, The composition for oral cavity of said [14] or [15]. [17] The oral composition according to any one of [1] to [16] above, which further contains a sugar alcohol other than the component (D).
- the content of water in the case of a dentifrice composition is preferably 10% by mass or more, more preferably 12% by mass or more, preferably 60% by mass or less, more preferably 50% by mass.
- the content of water in the case of a liquid oral composition is preferably 50% by mass or more, more preferably 70% by mass or more, still more preferably 80% by mass or more, preferably
- the content of the component (E) is preferably 0.3% by mass or more, more preferably 0.4% by mass or more, preferably 2% by mass or less, more preferably 1.5% by mass.
- the composition for oral cavity according to [20] which is not more than mass%.
- composition for oral cavity according to any one of [1] to [21], further comprising (F) a nonionic surfactant.
- component (F) is preferably one or more selected from polyglycerin fatty acid ester and sucrose fatty acid ester.
- the polyglycerol fatty acid ester of component (F) is preferably derived from a fatty acid having 12 to 20 carbon atoms, more preferably derived from a fatty acid having 12 to 18 carbon atoms. 23] oral cavity composition.
- the polyglycerin fatty acid ester of component (F) preferably has an average degree of condensation of glycerol of 2 to 20, more preferably an average degree of condensation of glycerin of 5 to 12 above [22] to [24] Any one oral cavity composition.
- the sucrose fatty acid ester of component (F) is preferably derived from a fatty acid having 6 to 20 carbon atoms, more preferably derived from a fatty acid having 10 to 18 carbon atoms, more preferably a carbon number.
- the content of component (F) is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, still more preferably 0.1% by mass or more, and still more preferably. Is any one of the above [22] to [26], which is 0.15% by mass or more, preferably 2% by mass or less, more preferably 1% by mass or less, and still more preferably 0.8% by mass or less. 1 oral composition.
- the content of component (G) is preferably 0.001% by mass or more, more preferably 0.005% by mass or more, still more preferably 0.008% by mass or more, and preferably 0
- the composition for oral cavity according to the above [28] which is not more than 1% by mass, more preferably not more than 0.03% by mass, and still more preferably not more than 0.02% by mass.
- the mass ratio ((A) + (B)) / (G) of the component (A) and the component (B) to the component (G) is preferably 0.5 or more, more preferably 1 or more.
- content of component (H) is preferably 1% by mass or more, more preferably 2% by mass or more, preferably 10% by mass or less, and more preferably 8% by mass or less.
- the composition for oral cavity. [33] The composition for oral cavity according to the above [1] to [32], which is a dentifrice composition.
- composition for oral cavity according to the above [1] to [34] for application in the oral cavity.
- composition for oral cavity according to the above [1] to [34] for producing a tooth cleansing agent.
- composition for oral cavity according to the above [1] to [34] for producing a protein stain removal agent for a tooth surface or a protein stain adhesion inhibitor for a tooth surface.
- a method for improving acid resistance of a tooth which comprises applying the oral composition of [1] to [34] to a tooth.
- Examples 1 to 9 Comparative Examples 1 to 4
- liquid oral compositions adjusted to pH 7 were prepared, and the protein soil removal effect, protein soil adhesion inhibitory effect and detergency were evaluated according to the following methods.
- the liquid oral compositions shown in Tables 1 and 2 were prepared so that the total amount was 100% by mass.
- ⁇ Evaluation test of protein stain removal effect A suspension in which 50 mg of hydroxyapatite (HAp) powder (HAP-200 Taihei Chemical Industrial Co., Ltd.) was mixed with 5 ml of purified water was produced. Next, 15 mg of albumin (bovine serum-derived Wako Pure Chemical Industries, Ltd. pH 5.2) was added to the suspension and allowed to stand for 90 minutes while shaking. The vibration was performed using a shaker (CUTE MIXER CM-1000 (EYERA Tokyo Rika Kikai Co., Ltd.)).
- HAp was prepared for. 1 mL of each liquid oral composition was added to these washed HAp and stirred for 2 minutes.
- the amount of protein remaining in HAp was determined by measuring fluorescence.
- a microplate fluorometer Gemini EM (Molecular Device Co., Ltd.) was used, and a fluorescence wavelength of 480 nm was measured at an excitation light wavelength of 360 nm.
- a calibration curve was prepared based on the fluorescence measurement results of the phosphate buffer solution of each concentration of albumin (phosphate buffer 0.1 mol, pH 8.4), and converted to the protein residual amount from the fluorescence measurement results.
- an albumin aqueous solution (bovine serum-derived Wako Pure Chemical Industries, Ltd., pH 5.2, 3 mg / mL) was added, and the mixture was allowed to stand for 90 minutes while vibrating as described above.
- the supernatant was removed by suction and washed with 300 mL of purified water twice as described above.
- 400 ⁇ L is taken out and mixed with 150 ⁇ L of fluorescent dye solution (fluorescamine 0.3 mg / mL acetone solution) did.
- a further 200 ⁇ L was taken out from the solution mixed with the fluorescent dye solution and allowed to stand in the dark for 30 minutes. After standing, the amount of protein adhering to HAp (protein adhesion amount) was determined by fluorescence measurement as described above.
- Comparative Example 2 containing only 0.01% by mass of component (A) has no effect of removing protein stains, but only 0.01% by mass of component (B) is contained.
- Example 1 where the component (B) 0.01% by mass and the component (A) 0.01% by mass are used in combination with the protein soil removal rate shown in Comparative Example 1, the protein soil removal rate is about twice as high. It can be confirmed that the protein dirt adhesion inhibition rate is also dramatically improved. Also, from the results of Table 2, it was confirmed that Example 9 had an excellent protein soil removal effect and a protein soil adhesion inhibitory effect as compared with Comparative Examples 3 to 4.
- composition for oral cavity of the present invention contains the specific amount of component (A) and component (B) in a specific mass ratio and a specific total amount, component (A) or component Compared with the case where (B) is used alone, it exhibits excellent detergency that exhibits a high protein stain removal effect and adhesion suppression effect, and has sufficient effects due to the combined use of these components (A) and (B). It is easy to see that
- the amount of plaque was quantified by the height from the gingiva in the area where the plaque adhered to the teeth, as shown in FIG. 3.
- the plaque amount of each dentifrice composition was the total amount of three panelists. 5) Note that the difference from the amount of plaque obtained for each dentifrice composition is defined as 100, where the amount of plaque when only brushing teeth until the plaque is zero and not brushing with the dentifrice composition is 100.
- the decrease rate (%) of protein stain adhesion was calculated as the decrease (protein stain adhesion suppression amount).
- the oral composition of the present invention (dentifrice) containing N-acylamino acid or a salt thereof and pyrophosphoric acid or a salt thereof in a specific amount, with a specific amount ratio and a specific total amount.
- the composition was applied to the human oral cavity, a good plaque formation inhibitory effect was observed.
- Examples 20 to 28, Comparative Examples 11 to 14 A dentifrice composition having the formulation shown in Table 6 was prepared, and the tooth surface feel and taste after use were evaluated in the same manner as in Example 10 above.
- flavor used by the Example and comparative example which are shown in Table 6 contained 5 mass% of anethole in 100 mass% of fragrance
- the composition for oral cavity (dentifrice composition) of the present invention is a combination of components (A), (B), and (C) while the tooth surface after use has a smooth cleaning feeling.
- the bitterness, gummy taste, or salty taste caused by this was suppressed, and an excellent feeling of use and effective cleaning were obtained.
- Comparative Examples 11 to 12 containing a large amount of the component (A) and the component (B) feel friction on the tooth surface after use and are not smooth. I felt.
- Comparative Examples 13 to 14 containing no component (A) or component (B) were insufficient in cleaning effectiveness after use as compared with the examples of the present invention.
- Example 29 Comparative Examples 15 to 16
- a dentifrice composition having the formulation shown in Table 7 was prepared, and the rate of soil adhesion inhibition was evaluated for the three panelists in the same manner as in Example 10 above.
- Table 7 shows the evaluation results.
- the oral composition (dentifrice composition) of the present invention containing N-acylamino acid or a salt thereof, an alkyl sulfate, and pyrophosphoric acid or a salt thereof in specific amounts, respectively, Even when it was applied to, a good plaque formation inhibitory effect was observed. That is, the composition for oral cavity of the present invention synergistically enhances the effect of removing protein stains and the effect of suppressing adhesion while providing a good cleaning effect and maintaining a good flavor and also suppressing plaque formation. It can be seen that it can greatly contribute.
- ⁇ Low temperature storage stability> The obtained liquid oral composition was placed in a transparent PET container and stored at 5 ° C. for 1 week, and the properties of the liquid were evaluated according to the following criteria. AA: Transparent. A: Slightly transparent. B: Precipitation occurs, but clears when returned to room temperature. C: Precipitation occurred and it became cloudy.
- the composition for oral cavity is transparent, regardless of the presence or absence of coloration, there is no dust or precipitate on the appearance, and the light transmittance at a wavelength of 550 nm (cell length 10 mm) is 90% or more. Say that.
- Mirror polishing is a polishing process in which three types of lapping films (manufactured by Sumitomo 3M) of abrasive paper 40 ⁇ m, 12 ⁇ m, and 3 ⁇ m are added with water in order from the roughest to the smallest.
- the pellets were taken out from the solution, immersed in the obtained liquid oral composition for 3 minutes, and then immersed in a solution having a final concentration (Ca concentration 1.5 mM, P concentration 5 mM) prepared newly. This cycle test was repeated 10 times. Thereafter, the pellets were taken out, the state of the deposits adhering to the pellet surface was observed with a scanning electron microscope, and the deposit suppression effect was determined according to the following criteria.
- B Some deposits were seen on the pellet surface.
- C Deposits were uniformly observed on the entire pellet surface.
- the composition for oral cavity of the present invention containing N-acylamino acid or a salt thereof and pyrophosphoric acid or a salt thereof in a specific amount, with a specific amount ratio and a specific total amount.
- Liquid oral composition not only provides a good feel after use even when applied to the human oral cavity, but also exhibits an excellent plaque formation inhibitory effect and is excellent even in a low-temperature environment It can be seen that it has storage stability and is excellent in acid resistance.
- the composition for oral cavity of the present invention synergistically enhances the effect of removing protein stains and suppresses adhesion while providing a good cleaning effect and maintaining a good aftertaste to form plaque. It can be seen that it can greatly contribute to suppression. Moreover, it turns out that it is excellent also in low-temperature storage stability and acid resistance.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
また、本発明の口腔用組成物であれば、プラーク中に沈着したリン酸カルシウム分がハイドロキシアパタイト結晶に転移し、さらに成長してしまうのを抑制することもできるので、より優れた歯垢形成抑制効果を期待できることを見出した。
さらに、本発明の口腔用組成物であれば、優れた耐酸性をも有するため、歯牙表面からのカルシウムイオンの溶出を効果的に抑制することができるとともに、低温環境下においても良好な安定性を保持でき、苦味や塩味等の不快な味の発現を抑制して良好な味をも呈することを見出した。
(A)N-アシルアミノ酸又はその塩 0.005質量%以上0.3質量%以下 及び
(B)ピロリン酸又はその塩 0.005質量%以上0.5質量%以下
を含有し、成分(A)と成分(B)の質量比((B)/(A))が0.05以上40以下であり、かつ成分(A)と成分(B)の含有量の合計が0.01質量%以上0.6質量%以下である口腔用組成物に関する。
本発明の口腔用組成物は、N-アシルアミノ酸又はその塩(A)を0.005質量%以上0.3質量%以下含有する。かかる成分(A)を特定の量で含有することにより、後述する特定の量のピロリン酸又はその塩(B)との併用によって、効果的にタンパク質汚れを除去しつつその付着をも有効に抑制することができる。また、本発明の口腔用組成物を使用した後の口腔内においては、歯面が汚れのない滑らかな状態であるときに触感できる、ギシギシとした引っかかり感のないつるつるとした感触を高め、いわゆる清掃実効感を十分に高めることができる。さらに、成分(A)特有の苦味の発現を抑制することもできるので、優れた洗浄性能と良好な味の実現とを両立させることも可能である。ここで、ギシギシとした引っかかり感のないつるつるした感触とは、歯面を舌でふれたときに、摩擦を殆ど感じずに舌をすべらせることができる歯の表面がなめらかな感触をいう。
[1]次の成分(A)及び(B):
(A)N-アシルアミノ酸又はその塩 0.005質量%以上0.3質量%以下 及び
(B)ピロリン酸又はその塩 0.005質量%以上0.5質量%以下
を含有し、成分(A)と成分(B)の質量比((B)/(A))が0.05以上40以下であり、かつ成分(A)と成分(B)の含有量の合計が0.01質量%以上0.6質量%以下である口腔用組成物。
[2]成分(A)と成分(B)の質量比((B)/(A))は、0.05以上であって、好ましくは0.1以上であり、40以下であって、好ましくは15以下であり、より好ましくは12以下である上記[1]の口腔用組成物。
[3]成分(A)と成分(B)の含有量の合計は、0.01質量%以上であって、好ましくは0.02質量%以上であり、0.6質量%以下であって、好ましくは0.45質量%以下であり、より好ましくは0.3質量%以下である上記[1]又は[2]の口腔用組成物。
[5]成分(A)は、好ましくは炭素数6~22のアシル基を有し、より好ましくは炭素数10~20のアシル基を有し、さらに好ましくは炭素数10~18のアシル基を有し、またさらに好ましくは炭素数12~18のアシル基を有する上記[1]~[4]いずれか1の口腔用組成物。
[6]成分(A)は、好ましくはN-アシル酸性アミノ酸又はその塩である上記[1]~[5]いずれか1の口腔用組成物。
[7]成分(A)は、好ましくはN-ラウロイルグルタミン酸、N-ミリストイルグルタミン酸、N-ココイルグルタミン酸、N-ラウロイルアスパラギン酸及びこれらの塩から選ばれる1種又は2種以上であり、より好ましくはN-ラウロイルグルタミン酸、N-ミリストイルグルタミン酸、N-ココイルグルタミン酸及びこれらの塩から選ばれる1種又は2種以上であり、さらに好ましくはN-ラウロイルグルタミン酸、N-ミリストイルグルタミン酸及びこれらの塩から選ばれる1種又は2種以上である上記[1]~[6]いずれか1の口腔用組成物。
[9]成分(B)は、好ましくはピロリン酸又はそのアルカリ金属塩であり、より好ましくはピロリン酸ナトリウムである上記[1]~[8]いずれか1の口腔用組成物。
[11]成分(C)は、好ましくはラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウム、パルミチル硫酸ナトリウム、ステアリル硫酸ナトリウム、オクチル硫酸ナトリウム及びカプリル硫酸ナトリウムから選ばれる1種又は2種以上であり、より好ましくはラウリル硫酸ナトリウムである上記[10]の口腔用組成物。
[12]成分(C)の含有量は、好ましくは0.5質量%以上であり、より好ましくは0.8質量%以上であり、さらに好ましくは1質量%以上であり、好ましくは2質量%以下であり、より好ましくは1.7質量%以下であり、さらに好ましくは1.5質量%以下である上記[10]又は[11]の口腔用組成物。
[13]成分(A)と成分(C)との質量比((C)/(A))は、好ましくは5以上であり、より好ましくは10以上であり、好ましくは200以下であり、より好ましくは150以下である上記[10]~[12]いずれか1の口腔用組成物。
[15]成分(D)は、好ましくはエリスリトール、マンニトール、α-D-グルコピラノシル-1,6-ソルビトール、α-D-グルコピラノシル-1,6-マンニトール、α-D-グルコピラノシル-1,6-ソルビトールとα-D-グルコピラノシル-1,6-マンニトールの混合物である還元パラチノースから選ばれる1種又は2種以上であり、より好ましくはエリスリトールである上記[14]の口腔用組成物。
[16]成分(D)の含有量は、好ましくは20質量%以上であり、より好ましくは25質量%以上であり、さらに好ましくは30質量%以上であり、好ましくは60質量%以下であり、より好ましくは55質量%以下であり、さらに好ましくは50質量%以下である上記[14]又は[15]の口腔用組成物。
[17]さらに成分(D)以外の他の糖アルコールを含有する上記[1]~[16]いずれか1の口腔用組成物。
[19]さらに研磨剤を1質量%以上20質量%、より好ましくは1質量%以上10質量%以下含有する上記[1]~[18]いずれか1の口腔用組成物。
[20]さらに粘結剤(E)を含有する上記[1]~[19]いずれか1の口腔用組成物。
[21]成分(E)の含有量は、好ましくは0.3質量%以上であり、より好ましくは0.4質量%以上であり、好ましくは2質量%以下であり、より好ましくは1.5質量%以下である上記[20]の口腔用組成物。
[23]成分(F)が、好ましくはポリグリセリン脂肪酸エステル及びショ糖脂肪酸エステルから選ばれる1種又は2種以上である上記[22]の口腔用組成物。
[24]成分(F)のポリグリセリン脂肪酸エステルは、好ましくは炭素数12~20の脂肪酸由来のものであり、より好ましくは炭素数12~18の脂肪酸由来のものである上記[22]又は[23]の口腔用組成物。
[25]成分(F)のポリグリセリン脂肪酸エステルは、好ましくはグリセリンの平均縮合度が2~20であり、より好ましくはグリセリンの平均縮合度が5~12である上記[22]~[24]いずれか1の口腔用組成物。
[26]成分(F)のショ糖脂肪酸エステルは、好ましくは炭素数6~20の脂肪酸由来のものであり、より好ましくは炭素数10~18の脂肪酸由来のものであり、さらに好ましくは炭素数12~14のものである上記[22]の口腔用組成物。
[27]成分(F)の含有量は、好ましくは0.01質量%以上であり、より好ましくは0.05質量%以上であり、さらに好ましくは0.1質量%以上であり、またさらに好ましくは0.15質量%以上であり、好ましくは2質量%以下であり、より好ましくは1質量%以下であり、さらに好ましくは0.8質量%以下である上記[22]~[26]いずれか1の口腔用組成物。
[29]成分(G)の含有量は、好ましくは0.001質量%以上であり、より好ましくは0.005質量%以上であり、さらに好ましくは0.008質量%以上であり、好ましくは0.1質量%以下であり、より好ましくは0.03質量%以下であり、さらに好ましくは0.02質量%以下である上記[28]の口腔用組成物。
[30]成分(A)及び成分(B)と成分(G)との質量比((A)+(B))/(G)は、好ましくは0.5以上であり、より好ましくは1以上であり、さらに好ましくは1.5以上であり、好ましくは30以下であり、より好ましくは25以下であり、さらに好ましくは12以下である上記[28]又は[29]の口腔用組成物。
[32]成分(H)の含有量は、好ましくは1質量%以上であり、より好ましくは2質量%以上であり、好ましくは10質量%以下であり、より好ましくは8質量%以下である上記[31]の口腔用組成物。
[33]歯磨組成物である上記[1]~[32]の口腔用組成物。
[34]液体口腔用組成物である上記[1]~[32]の口腔用組成物。
[36]上記[1]~[34]の口腔用組成物の歯を洗浄するための使用。
[37]上記[1]~[34]の口腔用組成物の歯面のタンパク質汚れを除去するための使用、又は歯面へのタンパク質汚れの付着を抑制するための使用。
[38]上記[1]~[34]の口腔用組成物の歯の耐酸性を向上させるための使用。
[39]歯面のタンパク質汚れの除去又は歯面へのタンパク質汚れの付着抑制に使用するための上記[1]~[34]の口腔用組成物。
[40]歯の耐酸性向上に使用するための上記[1]~[34]の口腔用組成物。
[41]上記[1]~[34]の口腔用組成物の歯の洗浄剤製造のための使用。
[42]上記[1]~[34]の口腔用組成物の歯面のタンパク質汚れ除去剤製造又は歯面へのタンパク質汚れ付着抑制剤製造のための使用。
[43]上記[1]~[34]の口腔用組成物の歯の耐酸性向上剤製造のための使用。
[44]上記[1]~[34]の口腔用組成物を歯に適用する歯の洗浄方法。
[45]上記[1]~[34]の口腔用組成物を歯に適用する歯面のタンパク質汚れ除去方法又は歯面へのタンパク質汚れ付着抑制方法。
[46]上記[1]~[34]の口腔用組成物を歯に適用する歯の耐酸性向上方法。
表1~2に示す処方にしたがい、pH7に調整した液体口腔用組成物を調製し、下記方法にしたがって、タンパク質汚れの除去効果、タンパク質汚れの付着抑制効果及び洗浄性を評価した。
なお、表1~2に示す各液体口腔用組成物は、全量100質量%となるように調製した。
ヒドロキシアパタイト(HAp)粉(HAP-200 太平化学産業(株))50mgを精製水5mlと混合した懸濁液を製造した。次に、懸濁液にアルブミン(ウシ血清由来 和光純薬(株)pH5.2)15mgを加えて振動させながら90分間おいた。なお、振動は、振盪機(CUTE MIXER CM―1000(EYERA東京理化器械(株)))を用いて行った。
ヒドロキシアパタイト(HAp)粉(HAP-200 太平化学産業(株))50mgを精製水5mlと混合した懸濁液を製造した。次に、このHAp懸濁液を75μLずつ取り出し、遠心分離機(3000rpm、5分)にかけた後に上澄み液を吸引除去して各液体口腔用組成物の評価用のHApを準備した。これらの洗浄後のHApに液体口腔用組成物1mLを加え、2分間攪拌した後、前述と同様に精製水300mLによる洗浄を2回行った。次にアルブミン水溶液(ウシ血清由来 和光純薬(株)pH5.2、3mg/mL)75μLを加え、前述と同様にして振動させながら90分間おいた。次に、遠心分離機(3000rmp、5分)にかけた後に上澄み液を吸引除去し、前述と同様に精製水300mLによる洗浄を2回行った。洗浄後のHApに1N塩酸 100μL、リン酸バッファー(0.1mol pH8.4)1mLを加えて攪拌した後、400μLを取り出し、蛍光色素溶液(フルオレスカミン 0.3mg/mL アセトン溶液)150μLを混合した。この蛍光色素溶液を混合した溶液から、さらに200μLを取り出して暗所に30分間静置した。静置後、HApに付着したタンパク質の量(タンパク質付着量)を、前述と同様の蛍光測定により求めた。
また、表2の結果からも、実施例9は、比較例3~4に比べ、優れたタンパク質汚れの除去効果を有するとともに、タンパク質汚れの付着抑制効果を有することが認められた。
表3~4に示す処方の歯磨組成物を調製し、下記方法にしたがって、使用後の歯面の感触の評価、及び味の評価を行った。
結果を表3~4に示す。
得られた歯磨組成物1gを歯ブラシにとって2分間歯をブラッシングした後、口腔内を水で数回すすぎ、その後の歯面を舌で触ったときの感触を下記基準にしたがって評価した。評価は専門パネラー2名で行い、協議による評価結果を表2に示す。
AA:歯面がなめらかな感触であり、清掃実効感が高い。
A :歯面がややきしむが、清掃実効感はある。
B :歯面がなめらかでなく、清掃実効感に乏しい。
C :歯面がギシギシする(歯面に摩擦を強く感じる)
得られた歯磨組成物1gを歯ブラシにとって2分間歯をブラッシングした後、口腔内を水で数回すすいだ。ブラッシング中の味及び水で数回すすいだ後味を下記基準にしたがって評価した。評価は専門パネラー2名で行い、協議による評価結果を表2に示す。
AA:苦味、えぐ味、及び塩味は感じられない。
A :極めて僅かに苦味、えぐ味、または塩味を感じる。
B :僅かに苦味、えぐ味、または塩味を感じる。
C :苦味、塩味及びえぐ味を感じる。
CC:極めて強い苦味またはえぐ味を感じる。
表5に示す処方の歯磨組成物を調製し、下記方法にしたがって、3名のパネラーについてタンパク質汚れ付着抑制率の評価を行った。実施例12を含め、評価結果を表5に示す。
《人でのタンパク質汚れの付着抑制率の評価》
1)予め歯科衛生士により、プラークがゼロになるまで歯をブラッシングした。
2)得られた歯磨組成物1gを歯ブラシにとって、歯科衛生士が2分間歯をブラッシングした。
3)その後、歯磨き、ブラッシング、洗口液による洗浄を行なうことなく、24時間、通常の生活を送った。
4)24時間後に、歯に付着した歯垢量を測定した。歯垢量の測定部位は1名につき上下左右4本ずつの16歯であって(1番、4番、6番、7番の歯)、測定箇所は図3に示すように歯間に位置する4箇所(測定箇所:X)と、平滑面に位置する6箇所(測定箇所:Y)の合計10箇所とした。歯垢量は、各測定箇所について図3に示すように、歯に歯垢が付着している領域の歯肉からの高さによって定量した。各歯磨組成物の歯垢量は3名のパネラーの合計量とした。
5)なお、プラークがゼロになるまでの歯のブラッシングを行うのみで歯磨組成物によるブラッシングを行っていない場合の歯垢量を100として、各歯磨組成物について求めた歯垢量との差を減少分(タンパク質汚れ付着抑制量)とし、タンパク質汚れ付着抑制率(%)を算出した。
表6に示す処方の歯磨組成物を調製し、上記実施例10において用いた方法と同様にして、使用後の歯面の感触、及び味の評価を行った。なお、表6に示す実施例と比較例で用いた香料には、香料100質量%中にアネトールが5質量%含有されており、リモネン及びピネンの合計の含有量は10質量%であった。
結果を表6に示す。
表7に示す処方の歯磨組成物を調製し、上記実施例10において用いた方法と同様にして、3名のパネラーについて汚れ付着の抑制率の評価を行った。評価結果を表7に示す。
表8~9に示す処方の液体口腔用組成物を調製し、下記方法にしたがって、各評価を行った。
結果を表8~9に示す。
得られた液体口腔用組成物10mLで口腔内を20秒間含嗽し、吐き出した直後の歯面を舌で触ったときの感触を下記基準に従って、評価した。評価は専門パネラー2名で行い、協議による評価結果を表8~9に示す。
AA:歯面がなめらかな感触であり、清掃実効感が高い。
A :歯面がややきしむが、清掃実効感はある。
B :歯面がなめらかでなく、清掃実効感に乏しい。
C :歯面がギシギシする(歯面に摩擦を強く感じる)。
得られた液体口腔用組成物で口腔内を20秒間含嗽し、吐き出した。含嗽中の味、及び吐き出した直後の後味を下記基準に従って、評価した。評価は専門パネラー2名で行い、協議による評価結果を表8~9に示す。
AA:異味を感じない。
A :ほとんど異味を感じない。
B :わずかに異味を感じる。
C :異味を感じる。
得られた液体口腔用組成物を透明PET容器に入れ、5℃で1週間保存し、液の性状を下記に示す判定基準にて評価した。
AA:透明である。
A :やや透明である。
B :沈殿が生じるが、室温に戻せば透明。
C :沈殿が生じ、白濁した。
なお、本発明において口腔用組成物が透明であるとは、着色の有無にかかわらず、外観上にごりや沈殿物がなく、波長550nmの光の透過率(セル長10mm)で90%以上であることを言う。
13.1mMのCaCl2溶液を9.1mL取り、精製水で70mLにしたのち、アルブミン(牛血清由来 和光純薬(株))を0.18g溶解させ、溶液を調整した。その溶液を攪拌しながら 40mM のK2HPO4溶液を10mL添加し、最終濃度(Ca濃度1.5mM、P濃度5mM)とした。その溶液に対して鏡面研磨処理を行ったヒドロキシアパタイトペレット(ペンタックスリコーイメージング(株))を30分間浸漬した。鏡面研磨とは研磨紙40μm, 12μm, 3μmの3種類のラッピングフィルム(住友スリーエム製)を粗い方から細かい順に水を含ませて研磨したものである。溶液から前記ペレットを取り出し、得られた液体口腔用組成物に3分間浸漬したのちに、さらに新しく調製した最終濃度(Ca濃度1.5mM、P濃度5mM)の溶液に浸漬した。このサイクル試験を10回繰り返し行った。その後前記ペレットを取りだし、前記ペレット表面に付着している沈着物の様子を走査型電子顕微鏡により観察し、沈着物の付着抑制効果を下記に示す判定基準により判定した。
A :付着物がなかった。
B :ペレット表面にやや付着物が見られた。
C :ペレット表面全体に一様に付着物が見られた。
ヒドロキシアパタイト粉((株)大平化学製)0.5gに対して、得られた液体口腔用組成物10mLを10分間作用させた後、遠沈し、上澄みを取り除いた。残部の粉体を水で洗浄した後、0.1Mの乳酸5mLを加え、5分間反応させた。その後、上澄みを取り出し、CaテストワコーE(和光純薬(株))を用いて溶出したカルシウムイオン濃度を測定し、下記に示す判断基準にて評価した。
A :カルシウムイオン濃度が1.5mM未満であった。
B :カルシウムイオン濃度が1.5mM以上~2M未満
C :カルシウムイオン濃度が2mM以上であった。
Claims (16)
- 次の成分(A)及び(B):
(A)N-アシルアミノ酸又はその塩 0.005質量%以上0.3質量%以下 及び
(B)ピロリン酸又はその塩 0.005質量%以上0.5質量%以下
を含有し、成分(A)と成分(B)の質量比((B)/(A))が0.05以上40以下であり、かつ成分(A)と成分(B)の含有量の合計が0.01質量%以上0.6質量%以下である口腔用組成物。 - 成分(A)が、炭素数6~22のアシル基を有する請求項1項に記載の口腔用組成物。
- 成分(A)が、N-アシル酸性アミノ酸又はその塩である請求項1又は2に記載の口腔用組成物。
- さらに(C)アルキル硫酸塩を0.5質量%以上2質量%以下含有する請求項1~3のいずれか1項に記載の口腔用組成物。
- 成分(A)と成分(C)の質量比((C)/(A))が、5以上200以下である請求項4に記載の口腔用組成物。
- 成分(B)が、ピロリン酸又はそのアルカリ金属塩である請求項1~5のいずれか1項に記載の口腔用組成物。
- さらに(F)ノニオン界面活性剤を含有する請求項1~6のいずれか1項に記載の口腔用組成物。
- 成分(F)が、ポリグリセリン脂肪酸エステル及びショ糖脂肪酸エステルから選ばれる1種又は2種以上である請求項7に記載の口腔用組成物。
- さらに(G)スクラロースを0.001質量%以上0.1質量%以下含有する請求項1~8のいずれか1項に記載の口腔用組成物。
- 成分(A)及び成分(B)と成分(G)の質量比((A)+(B))/(G)が、1以上30以下である請求項9に記載の口腔用組成物。
- 成分(A)と成分(B)の含有量の合計が0.02質量%以上0.45質量%以下である請求項1~10のいずれか1項に記載の口腔用組成物。
- 成分(A)と成分(B)の質量比((B)/(A))が0.1以上40以下である請求項1~11のいずれか1項に記載の口腔用組成物。
- さらに(D)20℃において水溶液100gに対して5~40g溶解する糖アルコールを含有する請求項1~12のいずれか1項に記載の口腔用組成物。
- さらに(H)グリセリンを1質量%以上10質量%以下含有する請求項1~13のいずれか1項に記載の口腔用組成物。
- 歯磨組成物である請求項1~14のいずれか1項に記載の口腔用組成物。
- 液体口腔用組成物である請求項1~14のいずれか1項に記載の口腔用組成物。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/400,644 US9211241B2 (en) | 2012-06-08 | 2013-06-07 | Oral composition |
CN201380030180.1A CN104363886B (zh) | 2012-06-08 | 2013-06-07 | 口腔用组合物 |
RU2014153494A RU2663700C2 (ru) | 2012-06-08 | 2013-06-07 | Состав для ухода за полостью рта |
EP13800196.1A EP2859881B1 (en) | 2012-06-08 | 2013-06-07 | Oral composition |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012131306A JP6072438B2 (ja) | 2012-06-08 | 2012-06-08 | 歯磨組成物 |
JP2012131288 | 2012-06-08 | ||
JP2012-131306 | 2012-06-08 | ||
JP2012-131288 | 2012-06-08 | ||
JP2012266282A JP6055296B2 (ja) | 2012-06-08 | 2012-12-05 | 口腔用組成物 |
JP2012-266282 | 2012-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013183748A1 true WO2013183748A1 (ja) | 2013-12-12 |
Family
ID=50345327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2013/065786 WO2013183748A1 (ja) | 2012-06-08 | 2013-06-07 | 口腔用組成物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9211241B2 (ja) |
EP (1) | EP2859881B1 (ja) |
CN (1) | CN104363886B (ja) |
RU (1) | RU2663700C2 (ja) |
TW (1) | TWI630919B (ja) |
WO (1) | WO2013183748A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017031124A (ja) * | 2015-08-05 | 2017-02-09 | 日油株式会社 | 化粧料汚れ付着防止剤および口腔用組成物 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6763725B2 (ja) * | 2016-09-06 | 2020-09-30 | 花王株式会社 | 口腔用組成物 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54117039A (en) * | 1978-02-27 | 1979-09-11 | Lion Dentifrice Co Ltd | Tooth polishing composition |
JPS6360917A (ja) * | 1986-09-02 | 1988-03-17 | Lion Corp | 口腔用組成物 |
JPH02256608A (ja) | 1988-10-20 | 1990-10-17 | Ajinomoto Co Inc | 歯磨組成物 |
JPH03200714A (ja) | 1989-12-27 | 1991-09-02 | Lion Corp | 口腔用組成物 |
JPH0912438A (ja) | 1995-06-28 | 1997-01-14 | Lion Corp | 口腔用組成物 |
JPH1017444A (ja) | 1996-07-05 | 1998-01-20 | Sunstar Inc | アミノ酸系界面活性剤含有口腔用組成物 |
JPH1121219A (ja) * | 1997-07-03 | 1999-01-26 | Lion Corp | 口腔用組成物 |
JP2005029506A (ja) * | 2003-07-14 | 2005-02-03 | Kao Corp | 口腔用組成物 |
JP2007161657A (ja) | 2005-12-15 | 2007-06-28 | Lion Corp | 歯磨組成物 |
JP2008143824A (ja) * | 2006-12-08 | 2008-06-26 | Lion Corp | 歯磨剤組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0364928B1 (en) | 1988-10-20 | 1994-04-06 | Ajinomoto Co., Inc. | Paste-like dentifrice composition |
JPH0825861B2 (ja) * | 1989-04-24 | 1996-03-13 | サンスター株式会社 | 歯磨組成物 |
US5900230A (en) * | 1997-08-18 | 1999-05-04 | Squigle, Inc. | Dental products to treat and prevent periodontal disease |
JP4392884B2 (ja) * | 1998-12-28 | 2010-01-06 | 旭化成ケミカルズ株式会社 | N−長鎖アシル酸性アミノ酸塩、およびその製造方法 |
US6682721B2 (en) * | 2000-03-17 | 2004-01-27 | Lg Household & Healthcare Ltd. | Patches for teeth whitening |
KR20080006109A (ko) * | 2006-07-11 | 2008-01-16 | 방금석 | 거품치약 조성물 |
JP2010143843A (ja) | 2008-12-18 | 2010-07-01 | Lion Corp | 液体口腔用組成物 |
CA2773738C (en) * | 2009-09-11 | 2016-06-07 | The Procter & Gamble Company | Methods and compositions for hydrophobic modification of oral cavity surfaces |
JP5846787B2 (ja) * | 2010-07-12 | 2016-01-20 | 花王株式会社 | 歯磨組成物 |
-
2013
- 2013-06-07 TW TW102120458A patent/TWI630919B/zh active
- 2013-06-07 RU RU2014153494A patent/RU2663700C2/ru active
- 2013-06-07 EP EP13800196.1A patent/EP2859881B1/en active Active
- 2013-06-07 WO PCT/JP2013/065786 patent/WO2013183748A1/ja active Application Filing
- 2013-06-07 US US14/400,644 patent/US9211241B2/en not_active Expired - Fee Related
- 2013-06-07 CN CN201380030180.1A patent/CN104363886B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54117039A (en) * | 1978-02-27 | 1979-09-11 | Lion Dentifrice Co Ltd | Tooth polishing composition |
JPS6360917A (ja) * | 1986-09-02 | 1988-03-17 | Lion Corp | 口腔用組成物 |
JPH02256608A (ja) | 1988-10-20 | 1990-10-17 | Ajinomoto Co Inc | 歯磨組成物 |
JPH03200714A (ja) | 1989-12-27 | 1991-09-02 | Lion Corp | 口腔用組成物 |
JPH0912438A (ja) | 1995-06-28 | 1997-01-14 | Lion Corp | 口腔用組成物 |
JPH1017444A (ja) | 1996-07-05 | 1998-01-20 | Sunstar Inc | アミノ酸系界面活性剤含有口腔用組成物 |
JPH1121219A (ja) * | 1997-07-03 | 1999-01-26 | Lion Corp | 口腔用組成物 |
JP2005029506A (ja) * | 2003-07-14 | 2005-02-03 | Kao Corp | 口腔用組成物 |
JP2007161657A (ja) | 2005-12-15 | 2007-06-28 | Lion Corp | 歯磨組成物 |
JP2008143824A (ja) * | 2006-12-08 | 2008-06-26 | Lion Corp | 歯磨剤組成物 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2859881A4 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017031124A (ja) * | 2015-08-05 | 2017-02-09 | 日油株式会社 | 化粧料汚れ付着防止剤および口腔用組成物 |
Also Published As
Publication number | Publication date |
---|---|
US20150098911A1 (en) | 2015-04-09 |
EP2859881A1 (en) | 2015-04-15 |
TWI630919B (zh) | 2018-08-01 |
CN104363886B (zh) | 2017-04-26 |
RU2014153494A (ru) | 2016-07-27 |
TW201402151A (zh) | 2014-01-16 |
EP2859881B1 (en) | 2019-11-06 |
CN104363886A (zh) | 2015-02-18 |
RU2663700C2 (ru) | 2018-08-08 |
US9211241B2 (en) | 2015-12-15 |
EP2859881A4 (en) | 2016-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104853726B (zh) | 包含四碱式锌‑氨基酸‑卤化物络合物的口腔护理产品 | |
EP2753292B1 (en) | Tooth remineralizing dentifrice | |
CN104981273B (zh) | 口腔护理组合物 | |
CN108601715A (zh) | 口腔护理组合物和使用该组合物的方法 | |
JPH06508349A (ja) | 抗歯石練り歯磨 | |
RU2526148C2 (ru) | Композиция зубной пасты | |
CN110769801B (zh) | 口腔护理组合物 | |
WO2013183748A1 (ja) | 口腔用組成物 | |
JP6055296B2 (ja) | 口腔用組成物 | |
JP2018065801A (ja) | 口腔用組成物 | |
JP6072438B2 (ja) | 歯磨組成物 | |
TWI832898B (zh) | 口腔用組合物 | |
JP5860572B1 (ja) | 口腔用組成物 | |
JP2007099632A (ja) | 歯牙の再石灰化促進方法 | |
JP2007505863A (ja) | 可溶性カルシウム金属イオン封鎖剤を含む組成物 | |
JP2007210913A (ja) | 液体口腔用組成物 | |
JP3961479B2 (ja) | 液体口腔用組成物 | |
JP2013112650A (ja) | 液体口腔用組成物 | |
JPS62151498A (ja) | 清浄剤 | |
JP2003231621A (ja) | 口臭予防用口腔用組成物 | |
JP7391612B2 (ja) | 口腔用組成物 | |
CN110087614A (zh) | 口腔护理组合物 | |
JP2022169428A (ja) | 口腔内装着器具用洗浄剤組成物 | |
JP6007660B2 (ja) | 口腔用組成物及び歯石形成抑制剤 | |
JP2015231973A (ja) | 液体口腔用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13800196 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14400644 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013800196 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: IDP00201407672 Country of ref document: ID |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2014153494 Country of ref document: RU Kind code of ref document: A |